Search Results - "Sedgwick, Martin L."

Effects of the class III antiarrhythmic drug dofetilide on ventricular monophasic action potential duration and QT interval dispersion in stable angina pectoris by Sedgwick, Martin L., Rasmussen, Henrik S., Cobbe, Stuart M.

“…The effects of intravenous dofetilide on ventricular monophasic action potential duration and effective refractory period at the right ventricular apex and…”
Get full text

Chemical cardioversion of atrial fibrillation with intravenous dofetilide by Sedgwick, Martin L., Lip, Greg, Rae, Alan P., Cobbe, Stuart M.

“…We studied the effects of two active dose levels of dofetilide (8 and 12 μg/kg) and placebo in 16 patients with recent onset atrial fibrillation. The study was…”
Get full text

Clinical and electrophysiologic effects of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with angina pectoris by Sedgwick, Martin L., Rasmussen, Henrik S., Cobbe, Stuart M.

“…Dofetilide (UK-68,798) is a new class III antiarrhythmic agent. In animal experiments it selectively prolongs the refractory periods parallel to the action…”
Get full text

The causative rhythm in out-of-hospital cardiac arrests witnessed by the emergency medical services in the Heartstart Scotland Project by Sedgwick, M L, Dalziel, K, Watson, J, Carrington, D J, Cobbe, S M

“…Out-of-hospital defibrillation has been shown to improve survival in out-of-hospital cardiac arrests. The maximum performance of defibrillation-based systems…”
Get more information